LabStyle Innovations Corp. (OTCQB:DRIOD)

Thriving with Diabetes In the mHealth Era

Disclaimer Regarding Forward-Looking Statements This presentation of LabStyle Innovations Corp. (the “Company”) and statements of the Company’s management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act").  Words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions all denote forward-looking statements within the meaning of the Act.  Factors that could cause or contribute to such differences include the Company’s compliance with regulatory requirements, the Company’s status as a new public company, the impact of current and any future competition, as well as other factors and risks discussed in the Company's filings with the U.S. Securities and Exchange Commission.  Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by Company management or its agents have been prepared by Company management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to the future performance of the Company. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles.

Flagship: Dario Personalized Smart Meter for Diabetes

Almost 10% of Americans today

1 in 3 American adults by 2050

The 5th leading cause of death in the world

www.mydario.com

Medical Companies HaveSpent Millions To Improve This Pack

www.mydario.com

Patients Still Have to Manage Their Own Condition Most of the Time

4 hours

8,756 Hours

www.mydario.com

To Manage Diabetes Effectively You Need a Combination of:

Tools MotivationInformation

www.mydario.com

Simple to use, Smart Meter™Plugs into smartphone Pocket-sized all-in-one Knowledge is empoweringPersonal pattern recognition & all information you need

You’re not alonePeer & Professional support

Value to Patients

Smart Meter

Knowledge

Support

www.mydario.com

Tools

Motivation

Information

Value to Payers

= =

Better testing &compliance

SavingsBetter care &prevention

www.mydario.com

Value to Supporters

Easier monitoring & remote support

Parents & children

www.mydario.com

Adults & older parentsCaregivers & PWDs

A Growing Market

$12b

$27b(Up

170%)

2013 2022www.mydario.com

CompetitorsDevices in the Market

www.mydario.com

www.mydario.com

 Apps in the Market

Competitors

The Only Personalized Smart Meter

www.mydario.com

Compact Tiny blood sample Highly accurate All-in-one device Automatically log & monitor Actionable alerts A1C estimates

2015

Q1 Q2 Q3 Q4

2013Q4

Europe & ROW

US

Q3

Major Milestones

CE Mark

Device Soft Launch iPhone(UK, Italy, NZ)

App Launch

FDA Submission

Launch (Australia and Netherlands)

www.mydario.com

2014

Q3 Q4Q2

Europe & ROW

US

Q1

Continuous work with FDA

Launch

Launch (Expansion in Europe, Canada)

Q2/Q3 Global reach (PwD coverage – 6.5M)

2.3

4

Current

#PwD (Millions)

0.2

2015 Global reach (6.5M -> 49M)

3

1

0.2

2.3

4

3

Dario

#PwD (Millions)

?

10

26

B2CDigital Marketing

App Users

Via Distributors

B2B Sales Force

Healthcare Professionals

Dario Direct

www.mydario.com

Soft Launch Examine Execution Capabilities

Product

• Improve compliance• Improves A1C

Supply chain

• Manufacturing• Increase inventory on demand• Smooth delivery & support

Sales & Marketing

• Sales/Marketing strategy works• CPA (Cost per acquisition)• Testimonials

www.mydario.com

Users feedback –

www.mydario.com

Multiple Potential Revenue Streams

• Out of pocket & reimbursement • Disposable Strips (razorblade model)

• Healthcare professionals - licenses• Payer risk-management & cost

reduction

• Clinical studies, trial recruitment • Partnerships

Software Platform

Device & Disposables

Data Monetization

www.mydario.com

Clinical Studies

Highest quality of

clinical standardsAccuracy

Compliant with new standard

Usability Study -240 Patients

89% claimed they will switch overnight

www.mydario.com

Comprehensive Intellectual Property

www.mydario.com

9 Patents : granted pending

Core technology – device/smartphone integration Device design Software design

In addition: Utility Model (1 granted)

9

3

1 8

1

4

4

Why Dario Why Now

www.mydario.com

Erez RaphaelCEO & President

BOD Director

Gadi LevinCFO

David EdelmanDirector Product Strategy

Seasoned executive with significant experience in publicly listed companies, capital market financings, accounting and financial management.

More than 15 years of software business experience, including managing positions in product development at both mobile and semi-conductor companies.

Eran KurmanVP, Global Strategy

Over 16 years of executive leadership in the Medical Device Industry. He has extensive experience in global strategic marketing, business development, and clinical development knowledge.

Experienced Management Team

Shosh FriedmanVP Clinical and Regulatory

Affairs (FRAP RAC)

Dror BacherVP, R&D

20 years of experience in building product organizations – from Design to commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens.

Entrepreneur and patient advocate who has dedicated his career to using technology to improve health and happiness. President of Diabetes Daily, a leading online community and educational platform.

Former SVP Clinical and Regulatory Affairs at Given Imaging (NASDAQ:GIVN). More than 20 years in clinical, regulatory affairs and QA systems.

www.mydario.com

Over 16 years of executive leadership in the Medical Device Industry. He has extensive experience in global strategic marketing, business development, and clinical development knowledge.

Entrepreneur and patient advocate who has dedicated his career to using technology to improve health and happiness. President of Diabetes Daily, a leading online community and educational platform.

Oren Fuerst, PhDChairman & Co-Founder

Malcolm HoenleinDirector

Dr. Steven KaplanDirector

CEO, Executive Vice-Chairman, Conference of Major American Jewish Organizations. Director, Council of Foreign Relations

Seasoned entrepreneur and investor. Founder of Tevel Global & Strategic Models Former faculty Columbia Business School. Extensive experience in medical devices and data management

World-renowned urologist and researcher. Co-founded numerous technology initiatives, including MediData Solutions (NASDAQ:MDSO) the largest clinical trials data management company.

Prof. Richard StoneDirector

Serves on the board of directors of multiple technology companies, including Powermat, Espro-Accoustiguide Group, Wellsense Technologies, NanoX Imaging and Check-Cap. Cofounded Lev Pharmaceuticals, Inc. which was sold to ViroPharma in 2008 for nearly $450 million in upfront consideration.

Board of Directors

Dennis McGrathDirector

Currently serves as President, CFO and board director of PhotoMedex, Inc. (NasdaqGS: PHMD,) joining the company in 2000

Rami YehudihaDirector

Marketing and advertising executive. From 2004 to the present, he has served as the Founder and Chief Executive Officer of LEAD, a top ten Israeli advertising firm. From 1997 to 2003, he served as the Chief Executive Officer at Ogilvy One Israel, a part of the WPP Group.

www.mydario.com

Prof Itamar Raz, MDHead of SAB

Gary ScheinerCDE MS

Hope WarshawMMSc RD CDE BC-ADM

Head of Diabetes Unit and Research Center, Hadassah Medical Center; Israel National Council of Diabetes of the Israel Ministry of Health; President, Israel Diabetes Research Group.

Dietitian and diabetes educator for nearly thirty-five years. Owner of consulting practice, Hope Warshaw Associates, LLC,. Her work today spans from corporate consulting to consumer and professional writing and individual diabetes and weight management counseling.

Dr. Paul RosmanDO FACP FACE FACOI

Scientific Advisory Board

Dr. William PolonskyPhD

Dr. Paolo Pozzilli MD

Professor of Medicine, Endocrinologist and Angiologist at the Munich Diabetes Research Group in Germany. Has developed his career in both Munich, and at the Joslin Diabetes Center at Boston in USA.

www.mydario.com

Has lived with type 1 diabetes since 1985 acknowledged as the 2014 Diabetes Educator of the Year by the American Association of Diabetes Educators. Known for his globally-available coaching services at IntegratedDiabetes.com.

An internationally recognized expert in the behavioral aspects of diabetes management. Co-founded the Behavioral Diabetes Institute He is author of numerous books, including the famed Diabetes Burnout: What to Do When You Can’t Take It Anymore.

Former Senior Medical Advisor at Eli Lilly & Company, has held teaching positions at Ohio University and Northeastern Ohio Universities College of Medicine, as well as served as President or Chair of American Diabetes Association, American Association of Clinical Endocrinologists, Ohio River Chapter, and the Ohio Diabetes Prevention and Control Program

Dr. Eberhard StandlMD

Professor of Endocrinology and Metabolic Diseases, Head of Department at the University Campus Bio-Medico in Rome, Italy in charge of the Post-Graduate School and PhD program in Endocrinology and Diabetes. He is also Professor of Diabetes Research at St.Bartholomew’s and the London School of Medicine.

Prof Itamar Raz, MDHead of SAB

Thank You.

Thriving with Diabetes, Together

Thriving with Diabetes In the Health Era